Safety and Immunogenicity Study of the Recombinant Hepatitis E Vaccine(Escherichia Coli) Coadministration With Recombinant Hepatitis B Vaccine
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 19 May 2017
At a glance
- Drugs Recombinant hepatitis E vaccine (Hecolin) (Primary) ; Hepatitis B vaccine
- Indications Hepatitis E
- Focus Adverse reactions
- Sponsors Xiamen Innovax Biotech
- 14 May 2017 Planned End Date changed from 1 Aug 2016 to 31 Oct 2017.
- 14 May 2017 Planned primary completion date changed from 1 Jun 2016 to 31 Oct 2017.
- 14 May 2017 Status changed from recruiting to active, no longer recruiting.